This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Herrmann M, Pusceddu I, März W, Herrmann W. Telomere biology and age-related diseases. Clin Chem Lab Med. 2018; 56(8): 1210–1222.HerrmannMPuscedduIMärzWHerrmannWTelomere biology and age-related diseases20185681210122210.1515/cclm-2017-087029494336Search in Google Scholar
Armstrong CA, Tomita K. Fundamental mechanisms of telomerase action in yeasts and mammals: understanding telomeres and telomerase in cancer cells. Open Biol. 2017;7(3): 160338.ArmstrongCATomitaKFundamental mechanisms of telomerase action in yeasts and mammals: understanding telomeres and telomerase in cancer cells20177316033810.1098/rsob.160338537670928330934Search in Google Scholar
Bernal A, Tusell L. Telomeres: Implications for Cancer Development. Int J Mol Sci. 2018; 19(1): 294.BernalATusellLTelomeres: Implications for Cancer Development201819129410.3390/ijms19010294579623929351238Search in Google Scholar
Zhu X, Han W, Xue W, Zou Y, Xie C, Du J, et al. The association between telomere length and cancer risk in population studies. Sci Rep. 2016; 6(1): 22243.ZhuXHanWXueWZouYXieCDuJThe association between telomere length and cancer risk in population studies2016612224310.1038/srep22243476810026915412Search in Google Scholar
Caocci G, Greco M, Delogu G, Secchi C, Martino B, Labate C, et al. Telomere length shortening is associated with treatment-free remission in chronic myeloid leukemia patients. J Hematol Oncol. 2016; 9(1): 63.CaocciGGrecoMDeloguGSecchiCMartinoBLabateCTelomere length shortening is associated with treatment-free remission in chronic myeloid leukemia patients2016916310.1186/s13045-016-0293-y496680027473052Search in Google Scholar
Okamoto K, Seimiya H. Revisiting Telomere Shortening in Cancer. Cells. 2019; 8(2): 107.OkamotoKSeimiyaHRevisiting Telomere Shortening in Cancer20198210710.3390/cells8020107640635530709063Search in Google Scholar
Srinivas N, Rachakonda S, Kumar R. Telomeres and Telomere Length: A General Overview. Cancers (Basel). 2020; 12(3): 558.SrinivasNRachakondaSKumarRTelomeres and Telomere Length: A General Overview202012355810.3390/cancers12030558713973432121056Search in Google Scholar
Jafri MA, Ansari SA, Alqahtani MH, Shay JW. Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies. Genome Med. 2016; 8(1): 69.JafriMAAnsariSAAlqahtaniMHShayJWRoles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies2016816910.1186/s13073-016-0324-x491510127323951Search in Google Scholar
Shay JW. Role of Telomeres and Telomerase in Aging and Cancer. Cancer Discov. 2016; 6(6): 584–593.ShayJWRole of Telomeres and Telomerase in Aging and Cancer20166658459310.1158/2159-8290.CD-16-0062489391827029895Search in Google Scholar
Pańczyszyn A, Boniewska-Bernacka E, Głąb G. Telomeres and Telomerase During Human Papillomavirus-Induced Carcinogenesis. Mol Diagn Ther. 2018; 22(4): 421–430.PańczyszynABoniewska-BernackaEGłąbGTelomeres and Telomerase During Human Papillomavirus-Induced Carcinogenesis201822442143010.1007/s40291-018-0336-x606142529777397Search in Google Scholar
Vinodhini K, Shanmughapriya S, Das BC, Natarajaseenivasan K. Prevalence and risk factors of HPV infection among women from various provinces of the world. Arch Gynecol Obstet. 2012; 285(3): 771–777.VinodhiniKShanmughapriyaSDasBCNatarajaseenivasanKPrevalence and risk factors of HPV infection among women from various provinces of the world2012285377177710.1007/s00404-011-2155-822159694Search in Google Scholar
Guan P, Howell-Jones R, Li N, Bruni L, de Sanjosé S, Franceschi S, et al. Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int J cancer. 2012; 131(10): 2349–2359.GuanPHowell-JonesRLiNBruniLde SanjoséSFranceschiSHuman papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer2012131102349235910.1002/ijc.2748522323075Search in Google Scholar
Wang X, Huang X, Zhang Y. Involvement of Human Papillomaviruses in Cervical Cancer. Front Microbiol. 2018; 9: 2896.WangXHuangXZhangYInvolvement of Human Papillomaviruses in Cervical Cancer20189289610.3389/fmicb.2018.02896627987630546351Search in Google Scholar
Park Y, Kim T-J, Hwang C-S, Cho CH, Jeong DH, Seong SJ, et al. Risk of cervical dysplasia among human papillomavirus-infected women in Korea: a multicenter prospective study. J Gynecol Oncol. 2019; 30(3). doi:10.3802/jgo.2019.30.e50.ParkYKimT-JHwangC-SChoCHJeongDHSeongSJRisk of cervical dysplasia among human papillomavirus-infected women in Korea: a multicenter prospective study201930310.3802/jgo.2019.30.e50642484330887765Open DOISearch in Google Scholar
Suligoi B, Vittori G, Salfa MC, Timelli L, Corsini D, Fattorini G, et al. Prevalence and incidence of external genital warts in a sample of Italian general female population. BMC Infect Dis. 2017; 17(1): 126.SuligoiBVittoriGSalfaMCTimelliLCorsiniDFattoriniGPrevalence and incidence of external genital warts in a sample of Italian general female population201717112610.1186/s12879-017-2202-6529473628166736Search in Google Scholar
Anorlu RI. What is the significance of the HPV epidemic? Can J Urol. 2008; 15(1): 3860–3865.AnorluRIWhat is the significance of the HPV epidemic?200815138603865Search in Google Scholar
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6): 394–424.BrayFFerlayJSoerjomataramISiegelRLTorreLAJemalAGlobal cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries201868639442410.3322/caac.2149230207593Search in Google Scholar
Kombe AJK, Li B, Zahid A, Mengist HM, Bounda G-A, Zhou Y, et al. Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation. Front Public Heal. 2020; 8.KombeAJKLiBZahidAMengistHMBoundaG-AZhouYEpidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation2020810.3389/fpubh.2020.552028785597733553082Search in Google Scholar
Zhang Y, Dakic A, Chen R, Dai Y, Schlegel R, Liu X. Direct HPV E6/Myc interactions induce histone modifications, Pol II phosphorylation, and hTERT promoter activation. Oncotarget. 2017; 8(56): 96323–96339.ZhangYDakicAChenRDaiYSchlegelRLiuXDirect HPV E6/Myc interactions induce histone modifications, Pol II phosphorylation, and hTERT promoter activation2017856963239633910.18632/oncotarget.22036570710329221209Search in Google Scholar
Molano M, Martín D, Moreno-Acosta P, Hernández G, Cornall A, Buitrago O, et al. Telomerase activity in cervical scrapes of women with high-grade cervical disease: A nested case-control study. Oncol Lett. 2017; 15(1): 354–360.MolanoMMartínDMoreno-AcostaPHernándezGCornallABuitragoOTelomerase activity in cervical scrapes of women with high-grade cervical disease: A nested case-control study201715135436010.3892/ol.2017.7324576807329387223Search in Google Scholar
Ustaoglu M, Bektas A, Bedir A, Bakir T, Duzgun A, Nar R, et al. The telomere length of gastric mucosal samples and peripheral blood lymphocytes in patients who have undergone Billroth II distal gastrectomy. Arch Med Sci. 2020; 16(3): 577–583.UstaogluMBektasABedirABakirTDuzgunANarRThe telomere length of gastric mucosal samples and peripheral blood lymphocytes in patients who have undergone Billroth II distal gastrectomy202016357758310.5114/aoms.2020.94656721221132399105Search in Google Scholar
Federal Budget Institute of Science Central Research Institute for Epidemiology. Guidelines to AmpliSens HPV HCR screen-titre-FRT PCR kit. Available at: https://interlabservice.ru/upload/iblock/a5b/Guidelines%20to%20AmpliSens%C2%AE%20HPV%20HCR%20screen-titre-FRT%20PCR%20kit%20(update%2028.07.2021).pdf.2018.Available at: https://interlabservice.ru/upload/iblock/a5b/Guidelines%20to%20AmpliSens%C2%AE%20HPV%20HCR%20screen-titre-FRT%20PCR%20kit%20(update%2028.07.2021).pdf.2018Search in Google Scholar
Federal Budget Institute of Science Central Research Institute for Epidemiology. AmpliSens HPV HCR genotype-titre-FRT PCR kit Instruction Manual. available at: http://www.theranostica.co.il/wp-content/uploads/2015/12/HPV-HCR-genotype-FRT-211212.pdf. 2018.available at: http://www.theranostica.co.il/wp-content/uploads/2015/12/HPV-HCR-genotype-FRT-211212.pdf. 2018Search in Google Scholar
Cawthon RM. Telomere measurement by quantitative PCR. Nucleic Acids Res. 2002; 30(10): 47e – 47.CawthonRMTelomere measurement by quantitative PCR2002301047e4710.1093/nar/30.10.e47Search in Google Scholar
Rao X, Huang X, Zhou Z, Lin X. An improvement of the 2^ (–delta delta CT) method for quantitative real-time polymerase chain reaction data analysis. Biostat Bioinforma Biomath. 2013; 3(3): 71.RaoXHuangXZhouZLinXAn improvement of the 2^ (–delta delta CT) method for quantitative real-time polymerase chain reaction data analysis20133371Search in Google Scholar
Wang L, Wang P, Ren Y, Du J, Jiang J, Jia X, et al. Prevalence of High-Risk Human Papillomavirus (HR-HPV) Genotypes and Multiple Infections in Cervical Abnormalities from Northern Xinjiang, China. PLoS One. 2016; 11(8):e0160698.WangLWangPRenYDuJJiangJJiaXPrevalence of High-Risk Human Papillomavirus (HR-HPV) Genotypes and Multiple Infections in Cervical Abnormalities from Northern Xinjiang, China2016118e016069810.1371/journal.pone.0160698Search in Google Scholar
Luo H, Belinson JL, Du H, Liu Z, Zhang L, Wang C, et al. Evaluation of Viral Load as a Triage Strategy With Primary High-Risk Human Papillomavirus Cervical Cancer Screening. J Low Genit Tract Dis. 2017; 21(1): 12–16.LuoHBelinsonJLDuHLiuZZhangLWangCEvaluation of Viral Load as a Triage Strategy With Primary High-Risk Human Papillomavirus Cervical Cancer Screening2017211121610.1097/LGT.0000000000000277Search in Google Scholar
Boscolo-Rizzo P, Rampazzo E, Polesel J, Giunco S, Menegaldo A, Mantovani M, et al. Predictive and prognostic significance of telomerase levels/telomere length in tissues and peripheral blood in head and neck squamous cell carcinoma. Sci Rep. 2019; 9(1): 17572.Boscolo-RizzoPRampazzoEPoleselJGiuncoSMenegaldoAMantovaniMPredictive and prognostic significance of telomerase levels/telomere length in tissues and peripheral blood in head and neck squamous cell carcinoma2019911757210.1038/s41598-019-54028-xSearch in Google Scholar
Plug-DeMaggio AW, Sundsvold T, Wurscher MA, Koop JI, Klingelhutz AJ, McDougall JK. Telomere erosion and chromosomal instability in cells expressing the HPV oncogene 16E6. Oncogene. 2004; 23(20): 3561–3571.Plug-DeMaggioAWSundsvoldTWurscherMAKoopJIKlingelhutzAJMcDougallJKTelomere erosion and chromosomal instability in cells expressing the HPV oncogene 16E6200423203561357110.1038/sj.onc.1207388Search in Google Scholar
Zhang A, Wang J, Zheng B, Fang X, Ångström T, Liu C, et al. Telomere attrition predominantly occurs in precursor lesions during in vivo carcinogenic process of the uterine cervix. Oncogene. 2004; 23(44): 7441–7447.ZhangAWangJZhengBFangXÅngströmTLiuCTelomere attrition predominantly occurs in precursor lesions during in vivo carcinogenic process of the uterine cervix200423447441744710.1038/sj.onc.1207527Search in Google Scholar
Rudolph KL, Millard M, Bosenberg MW, DePinho RA. Telomere dysfunction and evolution of intestinal carcinoma in mice and humans. Nat Genet. 2001; 28(2): 155–159.RudolphKLMillardMBosenbergMWDePinhoRATelomere dysfunction and evolution of intestinal carcinoma in mice and humans200128215515910.1038/88871Search in Google Scholar
O’Hagan RC, Chang S, Maser RS, Mohan R, Artandi SE, Chin L, et al. Telomere dysfunction provokes regional amplification and deletion in cancer genomes. Cancer Cell. 2002; 2(2): 149–155.O’HaganRCChangSMaserRSMohanRArtandiSEChinLTelomere dysfunction provokes regional amplification and deletion in cancer genomes20022214915510.1016/S1535-6108(02)00094-6Search in Google Scholar
Dong L, Wang MZ, Zhao X, Feng R, Hu S, Zhang Q, et al. Human papillomavirus viral load as a useful triage tool for non-16/18 high-risk human papilloma-virus positive women: A prospective screening cohort study. Gynecol Oncol. 2018; 148(1): 103–110.DongLWangMZZhaoXFengRHuSZhangQHuman papillomavirus viral load as a useful triage tool for non-16/18 high-risk human papilloma-virus positive women: A prospective screening cohort study2018148110311010.1016/j.ygyno.2017.11.01629169614Search in Google Scholar
Schlecht NF, Trevisan A, Duarte-Franco E, Rohan TE, Ferenczy A, Villa LL, et al. Viral load as a predictor of the risk of cervical intraepithelial neoplasia. Int J Cancer. 2003; 103(4): 519–524.SchlechtNFTrevisanADuarte-FrancoERohanTEFerenczyAVillaLLViral load as a predictor of the risk of cervical intraepithelial neoplasia2003103451952410.1002/ijc.1084612478669Search in Google Scholar
Zhang D, Chen J, Hong C, Yi D, Wang F, Cui W. High-risk human papillomavirus infection associated with telomere elongation in patients with esophageal squamous cell carcinoma with poor prognosis. Cancer. 2014; 120(17): 2673–2683.ZhangDChenJHongCYiDWangFCuiWHigh-risk human papillomavirus infection associated with telomere elongation in patients with esophageal squamous cell carcinoma with poor prognosis2014120172673268310.1002/cncr.2879724840723Search in Google Scholar
Castro-Duque AF, Loango-Chamorro N, Ruiz-Hoyos BM, Landázuri P. Telomerase activity associated with progression of cervical lesions in a group of Colombian patients. Rev Bras Ginecol e Obs. 2015; 37(12): 559–564.Castro-DuqueAFLoango-ChamorroNRuiz-HoyosBMLandázuriPTelomerase activity associated with progression of cervical lesions in a group of Colombian patients2015371255956410.1590/SO100-72032015000546226647844Search in Google Scholar
Pańczyszyn A, Boniewska-Bernacka E, Głąb G. Telomere length in leukocytes and cervical smears of women with high-risk human papillomavirus (HR HPV) infection. Taiwan J Obstet Gynecol. 2020; 59(1): 51–55.PańczyszynABoniewska-BernackaEGłąbGTelomere length in leukocytes and cervical smears of women with high-risk human papillomavirus (HR HPV) infection2020591515510.1016/j.tjog.2019.11.00732039800Search in Google Scholar